Development and Potential Utility of Dual and Triple NK Receptor Antagonists

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|3|12|1410-1422

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.3, Iss.12, 2003-08, pp. : 1410-1422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Utility of NK3 Receptor Antagonists for the Treatment of Schizophrenia

By  

Current Pharmaceutical Design, Vol. 16, Iss. 3, 2010-01 ,pp. : 344-357

Bentham Science Publishers

Access to resources Recommend Favorite

AMPA receptor agonists, antagonists and modulators: their potential for clinical utility

By Bigge C.F.   Nikam S.S.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1099-1114

Informa Healthcare

Access to resources Recommend Favorite

Development of endothelin receptor antagonists as potential therapeutic agents

By Ergul Adviye  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 33-44

Informa Healthcare

Access to resources Recommend Favorite

The Development of Cytokine Receptor Antagonists as Potential Therapeutic Agents for the Myeloproliferative Disorders

By  

Current Pharmaceutical Design, Vol. 8, Iss. 5, 2002-03 ,pp. : 357-368

Bentham Science Publishers

Access to resources Recommend Favorite

Substance P Receptor Antagonists in Psychiatry: Rationale for Development and Therapeutic Potential

By Herpfer Inga   Lieb Klaus  

CNS Drugs, Vol. 19, Iss. 4, 2005-01 ,pp. : 275-293

Adis International

Access to resources Recommend Favorite